Monte Financial Group’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.95M Buy
44,535
+1,137
+3% +$170K 2.23% 14
2026
Q1
$6.63M Sell
43,398
-625
-1% -$95.8K 2.35% 10
2025
Q4
$6.07M Sell
44,023
-2,560
-5% -$335K 2.26% 15
2025
Q3
$5.97M Sell
46,583
-5,879
-11% -$717K 2.2% 17
2025
Q2
$6.35M Sell
52,462
-492
-0.9% -$55.5K 2.47% 10
2025
Q1
$5.87M Sell
52,954
-769
-1% -$81.9K 2.57% 9
2024
Q4
$5.23M Buy
53,723
+15,610
+41% +$1.66M 2.24% 21
2024
Q3
$4.38M Buy
38,113
+114
+0.3% +$12.9K 1.82% 29
2024
Q2
$4.05M Buy
+37,999
New +$3.81M 1.79% 28

Other funds holding NVS

Monte Financial Group's NVS Position: Q2 2026 in Review

Monte Financial Group increased its Novartis (NVS) stake by 2.6% in Q2 2026, buying an estimated $170K and bringing the position to 44,535 shares worth $6.95M. The position accounts for 2.23% of the portfolio, ranked #14.

Monte Financial Group first reported a position in NVS in Q2 2024 and has held it in 9 quarters since. 1,620 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Monte Financial Group held 44,535 shares of Novartis worth $6.95M as of Q2 2026.
  • Monte Financial Group bought 1,137 Novartis shares in Q2 2026, an estimated $170K.
  • Novartis made up 2.23% of Monte Financial Group's portfolio in Q2 2026, its #14 holding.
  • Monte Financial Group first reported a position in Novartis in Q2 2024 and has held it in 9 quarters since.
  • 1,620 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Monte Financial Group's 13F filing for Q2 2026, filed 7 Aug 2026.